|
|
||||||||
Ann Thorac Surg 1989;48:222-227
© 1989 The Society of Thoracic Surgeons
Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Louisville School of Medicine, and the Jewish Hospital Heart and Lung Institute, Louisville, Kentucky USA
* Address reprint requests to Dr Gray, Department of Surgery, University of Louisville, Louisville, KY 40292.
The Pierce-Donachy ventricular assist device (VAD) was used as an attempted bridge to orthotopic cardiac transplantation in 12 patients aged 13 to 55 years. Ischemic (4 patients), dilated (4 patients), acute viral (1 patient), postpartum (1 patient), and hypertrophic cardiomyopathy (1 patient), along with a failed transplant (1 patient), were the causative factors of end-stage cardiomyopathy in these patients. All patients were candidates for orthotopic cardiac transplantation but sustained refractory cardiogenic shock (cardiac index <2 L/min/m2). Left VADs were placed in all patients; 7 also required right VADs. Four patients died of hemorrhagic complications less than 24 hours after VAD insertion. Ventricular assist device stabilization was successful in 8 patients and support ranged from eight hours to 64 days. Seven patients successfully underwent orthotopic cardiac transplantation. One died postoperatively of hemorrhagic complications, 6 were discharged from the hospital, and 1 patient died at 3 months of cytomegalovirus infection. Five patients are long-term survivors. The Pierce-Donachy VAD is an effective means for supporting critically ill patients with end-stage cardiomyopathy and cardiogenic shock before orthotopic cardiac transplantation. Death is related to hemorrhagic, rather than infectious or thromboembolic, complications. Patients successfully stabilized with the VAD can undergo orthotopic cardiac transplantation with acceptable mortality and morbidity rates.
This article has been cited by other articles:
![]() |
A. El-Banayosy, H. Posival, K. Minami, L. Arusoglu, L. Kizner, T. Breymann, D. Seifert, M. Korner, H. Kortke, O. Fey, et al. Mechanical circulatory support: lessons from a single centre Perfusion, March 1, 1996; 11(2): 93 - 102. [Abstract] [PDF] |
||||
![]() |
W. L. Holman, C. P. Murrah, E. R. Ferguson, R. C. Bourge, D. C. McGiffin, and J. K. Kirklin Infections During Extended Circulatory Support: University of Alabama at Birmingham Experience 1989 to 1994 Ann. Thorac. Surg., January 1, 1996; 61(1): 366 - 371. [Abstract] [Full Text] |
||||
![]() |
R. Korfer, A. El-Banayosy, H. Posival, K. Minami, M. M. Korner, L. Arusoglu, T. Breymann, L. Kizner, D. Seifert, H. Kortke, et al. Mechanical circulatory support: The Bad Oeynhausen experience Ann. Thorac. Surg., February 1, 1995; 59(suppl_1): S56 - S63. [Abstract] [PDF] |
||||
![]() |
D. J. Farrar and J. D. Hill Univentricular and biventricular thoratec VAD support as a bridge to transplantation Ann. Thorac. Surg., January 1, 1993; 55(1): 276 - 282. [Abstract] [PDF] |
||||
![]() |
J. E. Lowe, M. P. Anstadt, P. Van Trigt, P. K. Smith, P. J. Hendry, M. D. Plunkett, and G. L. Anstadt First successful bridge to cardiac transplantation using direct mechanical ventricular actuation Ann. Thorac. Surg., December 1, 1991; 52(6): 1237 - 1245. [Abstract] [PDF] |
||||
![]() |
M. S. Sweeney, D. E. Lammermeier, O. H. Frazier, C. M. Burnett, H. M. Haupt, and J. M. Duncan Extension of donor criteria in cardiac transplantation: Surgical risk versus supply-side economics Ann. Thorac. Surg., July 1, 1990; 50(1): 7 - 10. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |